Tilray Brands, Inc.
HealthcareNASDAQ:TLRY · NASDAQ Global Select
-$0.14 today
Vol 3.14M · Avg 4.67M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+23.27%
Period High
$21.00
Period Low
$3.60
Latest
$4.98
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Neogen Corporation
NASDAQ:NEOG
$1.98B
Dynavax Technologies Corporation
DVAX
$1.82B
Immunome, Inc.
NASDAQ:IMNM
$1.76B
Harrow Health, Inc.
NASDAQ:HROW
$1.40B
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$1.36B
Maze Therapeutics, Inc.
NASDAQ:MAZE
$1.33B
Alvotech
NASDAQ:ALVO
$1.30B
Phibro Animal Health Corporation
NASDAQ:PAHC
$1.28B
Evotec SE
NASDAQ:EVO
$966.11M
Amphastar Pharmaceuticals, Inc.
NASDAQ:AMPH
$885.83M
What is the latest TLRY filing?
The latest filing shown is 8-K dated Jun 9, 2026.
How many recent filings does TLRY have?
Intrinsic Alpha currently shows 20 recent filings for TLRY.
Explore More
Continue the stock analysis
Jump to another research area for this company.